Parkside Investments, LLC Amgen Inc Transaction History

Parkside Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$230.71 - $256.74 $22,609 - $25,160	-98 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $21,488 - $23,771	98 New	98 $23,000
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $1,784 - $2,082	-10 Closed	0 $0
Q3 2018 Oct 17, 2018	BUY	$185.29 - $208.89 $1,852 - $2,088	10 New	10 $2,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Parkside Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Parkside Investments, LLC with notifications on news.